Screener
Corcept Therapeutics CORT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $9.33B.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's market capitalization?
- Corcept Therapeutics (CORT) reported market capitalization of $9.33B in Q2 2026.
- How has Corcept Therapeutics's market capitalization changed year-over-year?
- Corcept Therapeutics's market capitalization increased by 14.7% year-over-year, from $8.14B to $9.33B.
- What is the long-term trend for Corcept Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Corcept Therapeutics's market capitalization has grown at a 3.9% compound annual growth rate (CAGR), from $3.02B to $3.66B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Corcept Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude